This section of the Zynex Medical InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Zynex Medical assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQZYXI
Beta0.67
Shares Outstanding38.5M
Average Volume (10 days)247.2K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)$0.47
Sales (TTM)$2.84
Book Value (MRQ)$1.69
Cash Flow (TTM)$0.42
Cash (MRQ)$0.62

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy3
 
Buy0
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Daniel J. Moorhead
Chief Financial Officer
(554)
Dispose
Jan 30, 2023
Thomas Sandgaard
Director, President, CEO and Chairman, Ten Percent Owner
(554)
Dispose
Jan 30, 2023
Anna Lucsok
Chief Operating Officer
(223)
Dispose
Jan 30, 2023
Anna Lucsok
Chief Operating Officer
(5,536)
Dispose
Jan 27, 2023
Anna Lucsok
Chief Operating Officer
5,000
Dispose
Jan 27, 2023

Recent SEC Filings

Amended >= 5% Acquisition
Feb 1, 2023
Insider Buy/Sell
Jan 30, 2023
Insider Buy/Sell
Jan 30, 2023
Insider Buy/Sell
Jan 30, 2023
Insider Buy/Sell
Jan 10, 2023